Benzinga Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. read more